Red Light Therapy for Dogs with Arthritis: What Pet Owners Need to Know

Canine arthritis affects an estimated 20–35% of adult dogs — and early signs are easy to miss. Here's what the research shows about red light therapy for joint-adjacent tissue support, and how to build it into a daily routine. 

WI
Winnie Jensen
Jul 21, 2026 15 min read
Red Light Therapy for Dogs with Arthritis: What Pet Owners Need to Know
Core Takeaway
Canine osteoarthritis is estimated to affect 20–35% of adult dogs, and early signs — slower mornings, reluctance to jump, reduced play — are easy to miss PBM supports mitochondrial ATP production and cellular signalling in joint-adjacent muscle and connective tissue through a non-thermal, non-invasive mechanism Two independent randomised controlled trials found significant improvements in pain scores and physical function in dogs receiving PBMT compared to control groups At-home PBM devices are a daily wellness complement to veterinary care — not a replacement for it A wrap-format device that covers the full joint area provides more consistent photon delivery than a handheld device for larger joints like the hips and shoulders

Canine osteoarthritis (OA) is one of the most common age-related changes in dogs — and one of the most frequently underestimated by owners. Unlike an acute injury with clear, dramatic symptoms, OA tends to develop gradually over months and years. The first signs are often subtle enough to be attributed to "slowing down with age" rather than recognised as a specific change worth discussing with a vet.

Understanding what OA involves, how red light therapy fits into a broader wellness approach for dogs living with it, and what the research shows is the starting point for making informed decisions about your dog's daily care.


How Common Is Arthritis in Dogs — and Why It's Often Missed

Osteoarthritis is a degenerative condition affecting the cartilage and surrounding structures of joints. Over time, the cartilage that cushions joint surfaces breaks down, leading to changes in the joint environment and the surrounding soft tissue. It is not exclusive to senior dogs — larger breeds in particular can show early joint changes from middle age — but it does become significantly more prevalent as dogs get older.

Estimates vary by study methodology, but the broader veterinary literature suggests osteoarthritis affects somewhere between 20% and 35% of adult dogs, with prevalence increasing substantially in dogs over seven years old. Some breed-specific studies — particularly for breeds predisposed to hip dysplasia, such as German Shepherds, Labrador Retrievers, and Golden Retrievers — report higher rates still.

What makes OA particularly easy to miss in early stages is that dogs rarely present with the kind of sudden, obvious lameness that prompts an immediate vet visit. Instead, the early signs tend to be gradual behavioural changes:

  • Slower to get up after resting, particularly in the morning
  • Reluctance to use stairs or jump onto furniture they previously accessed easily
  • Shorter walks or reduced enthusiasm mid-walk
  • Stiffness that eases once the dog has been moving for a few minutes
  • Reduced interest in play or interaction
  • Changes in posture or the way they sit and lie down

None of these signs are uniquely diagnostic of OA — they can reflect a range of conditions — which is why a veterinary assessment is always the right first step if you notice changes in your dog's movement or behaviour. The point here is simply that the subtlety of early OA signs means many dogs are living with significant joint changes before their owners register that anything has shifted.


How PBM Supports Joint-Adjacent Tissue

Red light therapy — Photobiomodulation (PBM) — works at the cellular level. Specific wavelengths of light (660nm and 850nm) are absorbed by Cytochrome c Oxidase (CCO), a photoreceptor within the mitochondrial respiratory chain. As Chung et al. (2012) describe, this absorption supports ATP production, modulates reactive oxygen species, and influences downstream cellular signalling — all through a photochemical process that does not involve heat, ionisation, or physical contact.[1]

This is a wellness mechanism, not a treatment mechanism. PBM does not alter the structural state of a joint or reverse cartilage degeneration. What it does is support the function of the cells in the tissue around and adjacent to joints — the muscles, tendons, ligaments, and connective tissue that are directly involved in how a dog moves and bears weight day to day.

This distinction matters for how you think about at-home PBM in the context of a dog with arthritis. The goal is not to address the underlying joint condition — that is a matter for your veterinarian. The goal is to support the tissue-level cellular function that contributes to your dog's everyday comfort and physical capacity alongside whatever veterinary care they are already receiving.

The 850nm near-infrared wavelength is particularly relevant here. Its longer wavelength allows it to penetrate 5–10mm beneath the skin surface — reaching into the muscle and connective tissue adjacent to joints, rather than working only at the surface level. For the hip, shoulder, and elbow joints that are most commonly affected in dogs with OA, this deeper reach is what makes the 850nm component most relevant to a joint-focused wellness session.

For a full explanation of how the two wavelengths differ in their tissue penetration, see: 660nm vs 850nm: What These Two Wavelengths Actually Do for Your Pet


What the Research Shows

PBM has one of the more substantial evidence bases in complementary veterinary medicine, and the research specifically in canine osteoarthritis is now sufficient to draw meaningful conclusions about the technology's role in a joint wellness context.

Looney et al. (2018) — Canine Elbow Osteoarthritis RCT

Looney et al. (2018) conducted a randomised, blinded, placebo-controlled trial examining PBMT in 20 dogs with naturally occurring elbow osteoarthritis. Dogs in the treatment group received six PBMT sessions over three weeks; dogs in the sham group received sessions with the device inactive. Both groups were assessed for lameness scores, pain scores, and NSAID use throughout the study period.[2]

The results were statistically significant across multiple measures. Dogs in the PBMT group showed significantly improved lameness scores compared to the sham group (P = 0.001), with a greater reduction in pain scores across 9 out of 11 measured parameters (P < 0.05). Nine out of 11 dogs in the treatment group were able to reduce their NSAID requirements during the study, compared to 0 out of 9 in the control group (P = 0.0003).

This is one of the more methodologically rigorous studies in the veterinary PBM literature — randomised, placebo-controlled, and using validated outcome measures — and its findings are specific to the joint-adjacent tissue support that PBM is designed to provide.

Alves et al. (2022) — Canine Hip Osteoarthritis RCT

A second randomised, double-blinded controlled trial by Alves et al. (2022), published in the American Journal of Veterinary Research, evaluated PBMT in 20 dogs with bilateral moderate to severe hip osteoarthritis. The treatment group received Class IV laser therapy at 14–20 J/cm² over three weeks; the control group received a 21-day course of meloxicam — a well-established NSAID used in veterinary pain management.[3]

The PBMT group showed better outcomes across multiple validated scoring instruments — including the Canine Brief Pain Inventory (pain interference and severity scores), the Liverpool Osteoarthritis in Dogs scale, and the Canine Orthopedic Index (function, gait, stiffness, and quality of life) — at the +8, +15, and +30 day assessment points. Joint range of motion improved in the PBMT group from +15 to +90 days. Kaplan-Meier analysis indicated that PBMT produced longer periods of improved outcomes compared to the meloxicam group.

It is important to note that both of these studies used clinical-grade laser equipment operating at higher power densities than home-use LED devices. The research establishes the scientific basis for PBM's role in supporting joint-adjacent tissue; home-use devices operate within a more conservative power range, and individual results vary between animals. These findings inform the rationale for at-home PBM as a wellness complement, not a clinical treatment equivalence.

Important context: Neither study should be interpreted as evidence that home-use PBM devices produce the same outcomes as clinical laser therapy. PBM is a wellness tool. Always consult your veterinarian regarding your dog's individual health needs.


Home Use vs. Veterinary Clinic: Understanding the Difference

If your dog has been diagnosed with OA, your vet may have already discussed laser therapy as part of a management plan. Understanding how clinic-based laser therapy and at-home PBM relate to each other is worth addressing directly.

Clinical-grade laser systems used in veterinary practices operate at significantly higher power densities than home-use LED devices — typically measured in watts rather than milliwatts, and often delivering energy at 14–20 J/cm² or higher per session. These sessions are conducted by trained professionals, often targeting specific joint areas with precision equipment. For dogs with significant OA, a course of in-clinic laser sessions may be part of an active management plan recommended by your vet.

Home-use LED devices operate within a considerably more conservative range, typically 20–50 mW/cm². They are wellness tools — designed for regular, daily use to support cellular function over time, rather than intensive short-course clinical intervention. The comparison is not one versus the other; they serve different functions within a dog's overall care.

Many owners whose dogs attend in-clinic laser sessions also use a home-use device between appointments — treating the home device as a daily maintenance tool that extends the consistent support between professional sessions. For a detailed breakdown of the practical and cost differences, see: Red Light Therapy at Home vs. Vet Clinic: What's the Real Difference?


Practical Considerations for Dogs with Joint Concerns

Which Areas to Cover

For dogs with OA, the most relevant areas to target in a home wellness session depend on which joints are affected. Here is a practical reference:

Hips: The most commonly affected site in medium to large breeds. Position the device over the hindquarters, covering the area from the base of the spine to the top of each rear leg. For dogs with bilateral hip involvement, a wrap format that covers the full hindquarter area provides the most consistent coverage.

Elbows and shoulders: Front limb joints are the second most common site. The elbow joint sits just below the shoulder, on the inner foreleg. Sessions targeting the forelimb should cover from the shoulder down to the elbow. For larger breeds, this area may require repositioning mid-session if using a handheld device.

Spine and lower back: Spinal changes often accompany hip OA in older dogs, particularly in breeds prone to intervertebral disc issues. Covering the lower back and sacral area in the same session as the hips is practical and efficient.

Knees (stifles): Particularly relevant for dogs with cruciate ligament history or patella issues. Position the device over the mid-to-lower rear leg.

Session Length and Frequency

For dogs being used alongside veterinary care for OA, daily sessions of 15–20 minutes are the most common approach. This aligns with the general guidance for home-use PBM — consistent daily use produces better cumulative outcomes than less frequent longer sessions.

The dose-response relationship in PBM is non-linear, as Hamblin (2016) notes — beyond a certain threshold, more light energy does not produce proportionally greater cellular response.[4] Consistent moderate sessions within the home-use range are the goal, not maximising session length or intensity. For full guidance on session parameters, see: How to Build a Red Light Therapy Routine Around Your Dog's Day

What to Observe Over Time

PBM is a cumulative practice. The effects build over weeks of consistent use rather than appearing immediately after a single session. For dogs with OA, the behavioural indicators most worth monitoring over time include:

  • Ease and speed of getting up after rest, particularly first thing in the morning
  • Willingness to navigate stairs, step into the car, or access their usual resting spots
  • Engagement with walks — pace, distance, enthusiasm
  • General activity level throughout the day
  • Coat condition around the treated areas, which often shows improvement within the first few weeks as a sign that the routine is having a surface-level effect

Keep in mind that OA is a progressive condition. The goal of a wellness routine is to support your dog's day-to-day comfort and physical capacity over time — not to reverse underlying joint changes. Any concerns about your dog's progression should always be discussed with your veterinarian.

When to Talk to Your Vet First

A brief conversation with your vet before starting a PBM routine is strongly advisable if your dog:

  • Is currently prescribed NSAIDs or other pain management medication for OA
  • Has recently undergone joint surgery or is in a post-operative recovery period
  • Has additional health conditions being managed alongside their OA
  • Is on any medication that may increase photosensitivity

This is not a reason to avoid PBM — it is standard good practice for any new addition to a dog's care routine, and your vet's guidance will help you integrate it appropriately.


Why Coverage Area Matters for Larger Joints

Osteoarthritis in dogs most commonly affects larger joints — hips, shoulders, and elbows — that span a significant surface area relative to the device coverage of a handheld wand. A handheld device positioned on one side of the hip joint may deliver consistent photon energy to that specific point, but the full joint-adjacent tissue area — the surrounding musculature, the soft tissue on the medial side, the structures along the lower back — is not covered in the same placement.

For joints that require broad, consistent coverage, a wrap-format device has a meaningful practical advantage. The device lies flat across the treatment area — covering the full hip and lower back region in a single placement, for example — without requiring the owner to reposition it manually or the dog to remain in a specific posture for each spot to be addressed.

The PawMoves Restore Red Light & Massage Wrap for Pets delivers both 660nm and 850nm wavelengths simultaneously across 444 LEDs distributed evenly across the wrap surface. Adjustable securing straps hold the device against the body regardless of the dog's position or minor movements during a session — which is particularly relevant for older dogs who shift position frequently or are uncomfortable remaining still. The 30-minute auto-shutoff runs sessions to completion without manual management.

The independent vibration massage function — six modes and 19 intensity levels — can be layered into sessions at the owner's discretion. Many owners of dogs with OA find that the vibration function at low settings is well-received during the latter part of a settled session, and it can be introduced gradually once the light routine is established.


Frequently Asked Questions

Can red light therapy replace my dog's arthritis medication?

No. At-home PBM devices are wellness tools — they are not medical devices and are not intended to replace veterinary treatment or prescribed medication. If your dog is currently on NSAIDs or other medication for OA, continue that plan as directed by your vet. PBM is designed to complement veterinary care, not substitute for it. Any changes to your dog's medication should be discussed with your veterinarian.

How often should I use red light therapy for a dog with arthritis?

Daily use is the approach most supported for dogs where consistent joint-adjacent tissue support is the goal. Most home routines involve sessions of 15–20 minutes once daily, or a minimum of five sessions per week. Consistency over time produces better cumulative outcomes than infrequent intensive use.

Is red light therapy safe to use alongside NSAIDs and other medications?

PBM is non-invasive, drug-free, and does not interact with medications through a pharmacological mechanism. That said, some medications increase photosensitivity, and a conversation with your vet before starting is always advisable if your dog is on any prescription medication.

How long before I might notice a difference?

PBM works cumulatively. Coat condition improvements are often among the first observable changes, typically within two to four weeks. Changes in how your dog moves, settles, and engages with daily activity tend to become more noticeable over six to eight weeks of consistent use. Every dog is different, and outcomes vary based on individual factors including age, overall health, and OA severity.

Can I use red light therapy on a dog that has had joint surgery?

Post-surgical use of PBM should always be discussed with your vet before starting. The parameters appropriate for post-operative use may differ from those for a general wellness routine, and your vet's guidance on timing and placement is important. PBM has been studied in post-surgical contexts — see our guide on Red Light Therapy for Pets: A Complete Guide to PBM and At-Home Wellness for more on the research — but home use following surgery specifically requires a vet conversation first.

Which breeds are most likely to benefit from a joint-focused PBM routine?

Breeds with a higher prevalence of hip dysplasia and OA — including Labrador Retrievers, Golden Retrievers, German Shepherds, Rottweilers, and Dachshunds — may benefit from proactive joint-adjacent wellness support as part of their routine from middle age onwards. That said, OA affects dogs across all breeds and sizes, and the decision to introduce PBM is not breed-specific — it is based on your individual dog's needs and your vet's guidance.


Related Reading


References

  1. Chung H, Dai T, Sharma SK, et al. The nuts and bolts of low-level laser (light) therapy. Ann Biomed Eng. 2012 Feb;40(2):516–533. PMID: 22045511. https://pubmed.ncbi.nlm.nih.gov/22045511/
  2. Looney AL, Huntingford JL, Blaeser LL, Mann S. A randomized blind placebo-controlled trial investigating the effects of photobiomodulation therapy (PBMT) on canine elbow osteoarthritis. Can Vet J. 2018 Sep;59(9):959–966. PMID: 30197438. https://pubmed.ncbi.nlm.nih.gov/30197438/
  3. Alves JC, Santos A, Jorge P, Carreira LM. A randomized double-blinded controlled trial on the effects of photobiomodulation therapy in dogs with osteoarthritis. Am J Vet Res. 2022 Aug;83(8). PMID: 35895799. https://pubmed.ncbi.nlm.nih.gov/35895799/
  4. Hamblin MR. Photobiomodulation or low-level laser therapy. J Biophotonics. 2016 Dec;9(11-12):1122–1124. PMID: 27973730. https://pubmed.ncbi.nlm.nih.gov/27973730/
Wellness Notice: PawMoves products are designed for general pet wellness and supportive care only. This article is for informational purposes and does not constitute veterinary advice. Always consult a qualified veterinarian regarding your pet's individual health needs.
Was this article helpful?
WI
Winnie Jensen Verified Author

Winnie Jensen is a pet wellness researcher and science writer with a focus on light therapy technologies for companion animals. She is dedicated to translating peer-reviewed research into accessible, evidence-based content for pet owners.